These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11336020)

  • 21. The volatile nature of pneumococcal serotype epidemiology: potential for misinterpretation.
    Black S
    Pediatr Infect Dis J; 2010 Apr; 29(4):301-3. PubMed ID: 19935444
    [No Abstract]   [Full Text] [Related]  

  • 22. Antibiotic-resistant pneumococci.
    Raymond NJ; Grimwood K
    N Z Med J; 1998 Mar; 111(1062):87-9. PubMed ID: 9577458
    [No Abstract]   [Full Text] [Related]  

  • 23. The public health ramifications of pneumococcal resistance.
    Reinert RR
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():1-3. PubMed ID: 19366361
    [No Abstract]   [Full Text] [Related]  

  • 24. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.
    Picazo JJ
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():4-6. PubMed ID: 19366362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005.
    Richter SS; Heilmann KP; Dohrn CL; Riahi F; Beekmann SE; Doern GV
    Clin Infect Dis; 2009 Feb; 48(3):e23-33. PubMed ID: 19115971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prevention of pneumococcal disease in children.
    Giebink GS
    N Engl J Med; 2001 Oct; 345(16):1177-83. PubMed ID: 11642234
    [No Abstract]   [Full Text] [Related]  

  • 27. Managing antibiotic resistance.
    Wenzel RP; Edmond MB
    N Engl J Med; 2000 Dec; 343(26):1961-3. PubMed ID: 11136269
    [No Abstract]   [Full Text] [Related]  

  • 28. Antimicrobial susceptibility of multidrug-resistant Streptococcus pneumoniae strains with penicillin MICs of 8 to 32 mg/L.
    Rodríguez-Cerrato V; Gracia M; Del Prado G; Huelves L; Naves P; Ruiz V; Ponte C; Soriano F
    Diagn Microbiol Infect Dis; 2010 Mar; 66(3):336-8. PubMed ID: 19939599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Streptococcus pneumoniae. The appearance of antibiotic resistance].
    Arredondo-García JL
    Gac Med Mex; 1997; 133(2):155-7. PubMed ID: 9254288
    [No Abstract]   [Full Text] [Related]  

  • 30. Pneumococcal vaccines for infants and children--past, present, and future.
    Klein JO
    Curr Clin Top Infect Dis; 2002; 22():252-65. PubMed ID: 12520657
    [No Abstract]   [Full Text] [Related]  

  • 31. An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents.
    Nuorti JP; Butler JC; Crutcher JM; Guevara R; Welch D; Holder P; Elliott JA
    N Engl J Med; 1998 Jun; 338(26):1861-8. PubMed ID: 9637804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pneumococcal vaccination: conjugated vaccine induces herd immunity and reduces antibiotic resistance].
    Traut V
    Dtsch Med Wochenschr; 2008 May; 133(22):1207-8; author reply 1208. PubMed ID: 18491279
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antibiotic resistance and serotype distribution of Streptococcus pneumoniae strains isolated from patients at Hacettepe University Medical Faculty].
    Yenişehirli G; Sener B
    Mikrobiyol Bul; 2003 Jan; 37(1):1-11. PubMed ID: 12838672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotype replacement in invasive pneumococcal disease: where do we go from here?
    Hanage WP
    J Infect Dis; 2007 Nov; 196(9):1282-4. PubMed ID: 17922390
    [No Abstract]   [Full Text] [Related]  

  • 35. Authors' reply to Prymula R. Re: "Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines" [Vaccine 27 (2009) 4739-4740].
    Rodgers GL; Arguedas A; Cohen R; Dagan R
    Vaccine; 2009 Sep; 27(40):5429-30. PubMed ID: 19643215
    [No Abstract]   [Full Text] [Related]  

  • 36. Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas.
    Techasaensiri C; Messina AF; Katz K; Ahmad N; Huang R; McCracken GH
    Pediatr Infect Dis J; 2010 Apr; 29(4):294-300. PubMed ID: 19949357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates that cause invasive disease among Chinese children.
    Xue L; Yao K; Xie G; Zheng Y; Wang C; Shang Y; Wang H; Wan L; Liu L; Li C; Ji W; Xu X; Wang Y; Xu P; Liu Z; Yu S; Yang Y
    Clin Infect Dis; 2010 Mar; 50(5):741-4. PubMed ID: 20113175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial-resistant Streptococcus pneumoniae: trends and management.
    Jacobs MR
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):619-35. PubMed ID: 18847402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential consequences of the pneumococcal conjugate vaccine.
    Kopterides P; Falagas ME
    N Engl J Med; 2006 Jul; 355(1):95; author reply 95-6. PubMed ID: 16823004
    [No Abstract]   [Full Text] [Related]  

  • 40. Pneumococcus and sickle cell disease: the beginning of the end?
    Steinberg MH
    Clin Infect Dis; 2007 Jun; 44(11):1434-5. PubMed ID: 17479938
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.